CD40-CD40L | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,224 results for “CD40-CD40L”

Trials

View all 742 →

CD40L Antagonism in Rheumatoid Arthritis (RA)

2 participants · First posted Apr 1, 2022

BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis

20 participants · First posted Dec 10, 2002

Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma

36 participants · First posted May 7, 2025

Drugs

View all 353 →

Investigational

Dapirolizumab pegol

CD40L-GVAX

rMVA-CD40L

Organizations

Eledon Pharmaceuticals

United States

News

View all 128 →

CD40 and CD70 Targeted Therapies Show Promise in Clinical Trials for Cancer and Autoimmune Diseases

Amgen's dazodalibep hits primary endpoint in first Phase 3 Sjögren's trial

Frexalimab Shows Promise in Treating Autoimmune Diseases by Targeting CD40 Ligand

Page 1 of 123